If you have symptoms of coronavirus - fever and cough, congestion, or shortness of breath - call the WP Hospital hotline at 914-681-2900.
A Message for Our Patients Regarding Coronavirus
Please note our new visitor guidelines; at this time no visitors will be allowed to enter our facilities.

Dan Costin, MD

Hematology & Oncology
2 Longview Avenue, Suite 300, White Plains, NY 10601
(914) 849-7630
(914) 849-7694

Biography

Dr. Dan Costin is Co-Medical Director of the White Plains Hospital Center for Cancer Care and Director of Cancer and Blood Specialists of New York. He has been practicing medical oncology and hematology in Westchester since 1993. He received his B.S. in biochemistry at the University of California in Los Angeles and his medical degree at the University of California in San Francisco. He completed his internal medicine residency at Beth Israel Hospital in Boston in 1990, his fellowship in medical oncology at the National Cancer Institute in Bethesda in 1991, and his fellowship in hematology at New York University in 1993. He has been an attending physician at White Plains Hospital since 1993 and served as section chief of the department of Hematology-Oncology from 1999 to 2007.

Dr. Costin is the founding member of Cancer and Blood Specialists of New York (CAB-SNY) and continues to this day as its medical director and laboratory director. After the Dickstein Cancer Treatment Center was completed in 1999, he relocated CAB-SNY into the newly designed free standing cancer center. He is one of the sentinel members of the White Plains Hospital Cancer Program and presently serves as co-medical director of the Program. He was chairperson of the Multidisciplinary Tumor Board Conference for 15 years, presiding over 750 meetings, at which time over 3000 patients were presented and discussed.

 

Read More Show Less

Dr. Costin has always had an active interest in research.  He has been principal investigator or co-investigator on over 50 different protocols offered at the White Plains Cancer Program over the past 15 years. He is the principal investigator on the following studies that are presently open at the Center for Cancer Care at White Plains Hospital:

Advanced solid malignancies:

  • STRONG protocol: an open-label, multi-center safety study of fixed-dose durvalumab and tremelimumab combination therapy or durvalumab monotherapy in advanced solid malignancies.

Bladder cancer:

  • STRONG bladder cancer protocol: safety study of fixed-dose durvalumab for patients with urothelial and non-urothelial carcinoma.

Breast cancer:

  • NSABP-B55: A Randomized double-blind Placebo-controlled multi-center Phase III study to assess the efficacy and safety of Olaparib versus placebo as adjuvant treatment in patients with Germline BRCA1/2 mutations and high risk HER2 negative primary breast cancer.
  • S1418: A Randomized phase III trial to evaluate the efficacy and safety of MK-3475 (pembrolizumab) as adjuvant therapy for triple receptor-negative breast cancer with >/=1 cm residual invasive cancer or positive lymph nodes after neoadjuvant chemotherapy.
  • GSK201973: A phase I/II dose escalation and expansion study to investigate the safety, pharmacokinetics, pharmacodynamics, and clinical activity of GSK525762 in combination with fulvestrant in subjects with ER+ breast cancer.

Gynecologic cancer:

  • NRG-GY004: A phase III study comparing single-agent Olaparib or the combination of cediranib and Olaparib to standard platinum-based chemotherapy in women with recurrent platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer.
  • NRG-GY-005: A randomized phase II/III study of the combination of cediranib and Olaparib compared to cediranib or Olaparib alone, or standard of care chemotherapy in women with recurrent platinum-resistant or –refractory ovarian, fallopian tube, or primary peritoneal cancer.

Liver cancer:

  • MK-3475-Keynote240: A phase III study of pembrolizumab versus best supportive care as second-line therapy in subjects with previously systemically treated advanced hepatocellular carcinoma.

Lung cancer:

  • CA209-CHECKMATE370: A master protocol of phase ½ studies of nivolumab in advanced NSCLC using nivolumab as maintenance after induction chemotherapy or as first-line treatment alone or in combination with standard of care therapies.
  • MK3474-Keynote407: A randomized double blind phase III study of carboplatin-Paclitaxel/Nab-paclitaxel chemotherapy with or without pembrolizumab in first line metastatic squamous non-small cell lung cancer.
  • Lung biopsy study: Next generation DNA sequencing of malignant tumors obtained by Lung biopsy – a prospective clinical registry.

Malignant melanoma:

  • E3612: A randomized  phase II trial of Ipilimumab with or without Bevacizumab in patients with unresectable stage III or stage IV melanoma.

Myelodysplastic syndrome (MDS) / acute myeloid leukemia (AML):

  • Onconovoa 09-08: Phase I/II, multi-center, dose-escalating study of the tolerability, pharmacokinetics, and clinical activity of the combined administration of oral rigosertib with azacitidine in patients with MDS or AML.

Prostate cancer:

  • S1216: A phase III randomized trial comparing androgen deprivation therapy + TAK-700 with androgen deprivation therapy + bicalutamide in patients with newly diagnosed metastatic hormone sensitive prostate cancer.

Renal cancer:

  • EA8143 (PROSPER RCC): A phase III randomized study comparing perioperative nivolumab versus observation in patients with localized renal cell carcinoma undergoing nephrectomy.

Sarcoma:

  • A091304: A phase I/II randomized study of MLN0128 versus Pazopanib in patients with locally advanced unresectable and/or metastatic sarcoma.

Supportive and complementary care:

  • DEALS-EPS: Dietary education and livestrong exercise program study.
  • Tommie Copper: Pilot evaluation of Tommie copper material and its impact on pain control.

Dr. Costin is also a co-investigator on several other open studies at Center for Cancer Care at White Plains Hospital, including:

  • A011106: alternate approaches for clinical stage II or III estrogen receptor positive breast cancer in postmenopausal women.
  • AO11401: trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer.
  • A011502: randomized phase III double-blinded trial of aspirin as adjuvant therapy for node positive HER2 negative breast cancer – the ABC trial.
  • E2112: randomized phase III trial of endocrine therapy plus entinostat/placebo in postmenopausal patients with hormone receptor positive advanced breast cancer.
  • NRG-BR003: randomized study of adjuvant therapy comparing AC followed by paclitaxel with our without carboplatin for node-positive or high-risk node-negative triple negative invasive breast cancer.
  • S1207: phase III randomized clinical trial evaluating adjuvant endocrine therapy +/- one year of everolimus in patients with high-risk hormone receptor-positive and HER2 negative breast cancer.
  • S1416: phase II randomized placebo-controlled trial of cisplatin with or without Veliparib in metastatic triple-negative breast cancer and/or BRCA mutation-associated breast cancer.
  • A081105: randomized double blind placebo controlled study of erlotinib or placebo in patients with completely resected EGFR mutant non-small cell lung cancer.
  • A151216: Adjuvant lung cancer enrichment marker identification and sequencing trial (ALCHEMIST).
  • E4512: phase III double-blind trial for surgically resected early stage non-small cell lung cancer – crizotinib versus placebo for patients with tumors harboring the anaplastic lymphoma kinase (ALK) fusion protein.
  • EA5142: A randomized phase III study of nivolumab after surgical resection and adjuvant chemotherapy in non-small cell lung cancer (ANVIL).
  • E3106: randomized phase III trial of lenalidomide versus observation alone in patients with asymptomatic high-risk smoldering multiple myeloma.
  • S1513: randomized phase II study of 2nd line FOLFIRI versus modified FOLFIRI with PARP inhibitor ABT-888 (Veliparib).
  • EAY131: molecular analysis for therapy choice (MATCH).

Dr. Costin lives in White Plains with his wife Sandra and their two beautiful children, Diana and Jeremy. He enjoys golf, art, photography, opera, and literature.

Awards & Honors

  • New York Magazine:  NY’s Best Doctors- Medical Oncology- 2018
  • Castle Connolly Top Doctors-Medical Oncology & Hematology-2018 & 2019
  • 2004 – American College of Physicians – Fellow
  • 1992-1993 – American Cancer Society Clinical Oncology Fellowship Award
  • 1983 – University of California, Los Angeles – Phi Beta Kappa, summa cum laude

Insurance Plans Accepted

  • AETNA
  • AFFINITY
  • BLUE CROSS
  • CIGNA
  • GHI
  • HEALTH INSURANCE PLAN OF NEW YORK (HIP)
  • HUDSON HEALTH
  • MAGNACARE
  • MULTIPLAN
  • MVP
  • OXFORD
  • POMCO
  • TRICARE
  • UNITED HEALTHCARE

Recent Patient Comments

Press Ganey
5
01/28/2020
Dr Costin is the best! As is his team of nurses and assistants.
5
01/12/2020
Dr. Dan Costin is highly recommended.
5
01/10/2020
*Dr. Costin & his entire staff are extremely dedicated, professional, courteous & caring.
5
01/02/2020
Dr. Costin is a wonderful, kind and caring doctor. He always takes time with his patients, discusses your health results and always asks if I have any questions or concerns. I am very fortunate to have him as my doctor.
5
12/27/2019
I am very satisfied with the level of service professionalism & experience of the team of doctors I see at W.P. Physicians Assoc. (oncology, surgery, endocrinology gastro cardio). (I thank all of them).
5
12/23/2019
Excellent doctor and superb team all around. Always a great experience. Dr Costin is the best there is.
5
12/17/2019
excellent experience
5
11/25/2019
*Dr. Costin is THE best -
5
11/25/2019
he saved my life excellent doc
5
11/24/2019
the nurse was very courteous and made me feel at ease.Dr Costin is very caring. he knows my history very well and read all recent tests before talking with me and assuring me that I am doing well.
5
11/21/2019
*Dr. Costin is an excellent compassionate health provider. I am very happy to be his patient.
5
11/07/2019
Everyone was excellent Dr. Costin, the nurses & techs and the receptionists.
5
11/04/2019
My visit was excellent...all concerned were excellent. Dr. Costin took great care with every part of the visit.
5
11/03/2019
White Plains Hospital, staff and doctors have been excellent in every regard. Dr. Costin spent a great deal of time with me on my first visit, explaining procedures and possible outcomes. His office assistant has always followed up with meticulous concern, providing information and updating schedules, as necessary.
5
10/28/2019
Very caring and professional
5
10/28/2019
Dr. Costin is always wonderful. I'm with the best!
5
10/26/2019
Very thorough and excellent follow up!
5
10/13/2019
always a friendly and warm experience. Dr Costin is a wonderful, debited and caring doctor. I am blessed to have him caring for me.
5
10/08/2019
Always excellent
5
09/29/2019
Always a friendly, professional, efficient and competent staff.
5
09/24/2019
Dr. Costin is the MOST compassionate, understanding and kind doctor I have ever come across. I would recommend him to ANYONE and am so glad I was able to come under his care. White Plains Hospital is lucky to have him as a part of their team.
5
09/23/2019
Dr. Costin is just an amazing. Brilliant, articulate and caring. Gives me his undivided attention always. I am blessed to have such a great team of dr's. caring and looking out for me. The entire WP Staff is a 10!
5
09/23/2019
excellent staff. Always helpful and kind.
5
09/19/2019
always receive wonderful care.
5
09/19/2019
All visits very good -
5
09/18/2019
Treatment and care was very great.
5
09/14/2019
Excellent.
5
09/07/2019
always an excellent experience. Doctor & Staff are professional, courteous and kind.
5
08/29/2019
Excellent care, excellent staff. *Dr. Costin is wonderful!
5
08/27/2019
Everyone helpful with a positive attitude
5
08/27/2019
Dr. Costin and his staff, including all in the infusion center are excellent health care providers. I can't imagine going anywhere else. Also, all of my experiences at White Plains Hospital have been excellent.
5
08/24/2019
was made to feel at ease and that my concerns and questions were valid. Information given me was clear and understandable.
5
08/22/2019
I always have a good experience with the doctor and his assistants -
5
08/19/2019
it's always bin very good experience. The staff is well informed and always helpful.
5
08/19/2019
Always a wonderful experience. Most outstanding provider and fabulous staff
5
08/19/2019
Dr Costin and his staff are excellent. Very thorough and so very caring.
5
08/19/2019
love this office. always feel special, respected and cared for
5
08/19/2019
always a positive experience with Dr Costin
5
08/18/2019
everyone in the office is very helpful and understanding I always have a good experience when I go to the Cancer Center
5
08/12/2019
they do an incredible job..... everyone including Dr Costin
4.88
08/11/2019
Dr. Made me feel at ease and confident about my upcoming procedure and follow up care .
5
08/08/2019
Great experience with *Dr. Costin and the nurses. Receptionist was warm.
5
07/28/2019
Nurses are warm and professional. Dr. Costin is exceptional in his approach to care and bedside manner.
5
07/27/2019
I have never experienced the kind of care given with Dr. Costin and his office staff. they are all wonderful, kind, compassionate, and informative group of people
5
07/25/2019
*Dr. Costin is truly an exceptional medical provider. I found him to be comforting, caring & EXTREMELY THOROUGH regarding my medical conditions. During my consultation he was knowledgeable regarding all of my medical history & records. He carefully took all this information into consideration when deciding on the next steps to take and which medication would be best for me.
5
07/16/2019
Dr. Costin and his staff are fabulous. I would rate Dr. Costin as "irreplaceable". He is an outstanding physician in every way.
5
07/09/2019
excellent MD and staff.
5
07/09/2019
This was my first visit to Dr. Costin and I was very pleased with his concern and professionalism.
5
07/07/2019
best doctor ever! wonderful staff!
5
07/04/2019
I was diagnosd cancer on the rectum. I went through Chemo and Radiation Therapy at Cancer Center by White Plains Hospital. The nurses, practytional nurses and the whole stuff were very profesional, very attentive to me need and very compation. i am going recomended to my family and friends, when they will in similar situation
5
06/27/2019
*Dr. Costin is very kind, caring, excellent disposition. He makes the visit as pleasant as possible.
5
06/27/2019
Dr Costin is the greatest cancer doctor on Earth!
5
06/25/2019
best group
5
06/24/2019
Always excellent individual attention - the very best -thank you
5
06/11/2019
Excellent experience.
4.88
06/03/2019
I have complete confidence in *Dr. Costin.
5
05/31/2019
This office staff makes you feel very comfortable.Dr. Costin has a warm and understanding attitude with the patient and Love him for that.would recommend him to others.
5
05/23/2019
Excellent staff & doctor!
5
05/21/2019
Great
5
05/20/2019
A doctor's visit is usually not a pleasant experience, but Dr. Costin is the exception. He and his staff create a pleasant atmosphere while maintaining their professionalism.
5
05/19/2019
Dr. Dan Costin is an excellent, caring, understanding and pleasant doctor. I feel very safe and know that I am in exceptional good care and would highly recommend him in a heartbeat. I
5
05/12/2019
Dr. Costin and the Cancer Center from White Plains Hospital are super. I don't know any other doctor in my 68 years, that is even close to the knowledge, empathy, and personality log Dr. Costin. I feel privileged to be a patient of Dr. Costin.
5
05/07/2019
To me *Dr. Costin is the model of the warm, caring, devoted and skilled physician. Our family is fortunate to have him.
5
05/07/2019
Dr Costin and his staff are extremely professional, courteous and kind.
5
05/02/2019
Dr. Costin and his staff are the BEST!!!!
5
04/28/2019
Dr. Costin and his entire team are exceptional in every way.
5
04/28/2019
The best Doctor ever
5
04/19/2019
Everyone is always very professional.
5
04/16/2019
Excellent as always.
5
04/16/2019
very friendly professional staff
5
04/13/2019
Everything went well as do all my visits with Dr. Costin.
5
04/08/2019
To date my experience has been entirely positive and life giving.
5
04/08/2019
Excellent nursing and medical services
5
04/08/2019
Dr Costin is and has always been a superb doctor and a wonderful human being. A major asset to WPH

    In The News

    Read more news at Health E-Talk and listen to all our Podcast at Health Talk

    Education & Training

    Medical Degree
    • University of California, San Francisco
    Post-graduate Training
    • Fellowship, Medical Oncology - National Cancer Institute, Bethesda
    • Fellowship, Hematology - New York University, New York
    • Residency, Internal Medicine - Beth Israel Hospital, Boston
    Board Certification(s)
    • American Board of Medical Oncology
    • American Board of Hematology
    • American Board of Internal Medicine
    Membership(s)
    • American College of Physicians
    • American Medical Association
    • American Society of Hematology
    • American Society of Clinical Oncology
    • Massachusetts Medical Society

    Institutional Affiliations

    • White Plains Hospital
    • Burke Rehabilitation Hospital
    Dan Costin, MD

    Overall Satisfaction

    4.9 / 5
    287 Ratings | 74 Comments